ASBPW

Aspire Biopharma Warrant
ASBPW

Overview Fund Trends Analyst Outlook Journalist POV

36 hedge funds and large institutions have $7.27M invested in Aspire Biopharma Warrant in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.1M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.4M
2
+$1.5M
3
+$179K
4
SCM
Saba Capital Management
New York
+$157K
5
LA
Linden Advisors
New York
+$144K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.4M
2
$1.5M
3
$179K
4
$161K
5
$157K
6
$144K
7
$80K
8
$80K
9
$68K
10
$63K
11
$60K
12
$60K
13
$36K
14
$31K
15
$30K
16
$24K
17
$24K
18
$24K
19
$21K
20
$21K
21
$17K
22
$13K
23
$13K
24
$12K
25
$12K
1
2